By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Probiodrug AG 

Weinbergweg 22

Halle (Saale)    D-06120  Germany
Phone: 49-345-5559900 Fax: 49-345-5559901


Company News
Probiodrug AG Release: Data On Glutaminyl Cyclases (Qcs) In Its Relation To Alzheimer’s Disease (AD) Published In Acta Neuropathologica 3/3/2015 7:52:36 AM
German Alzheimer's Drug Developer Probiodrug AG Plans Amsterdam IPO 9/29/2014 8:02:54 AM
Probiodrug AG Presents Pre-clinical And Clinical Findings Of PQ912, A QC-Inhibitor For Alzheimer's Disease 7/31/2014 11:47:53 AM
Probiodrug AG Presents Development Overview Of PQ912, Probiodrug’s QC-Inhibitor For Alzheimer’s Disease 7/10/2014 6:20:59 AM
Probiodrug AG To Present At 2014 Asia Biotech Invest Conference 6/2/2014 7:40:33 AM
Probiodrug AG To Present At Annual BioEquity Europe Conference 5/19/2014 6:45:14 AM
Probiodrug AG And VU University Medical Center In Amsterdam To Collaborate On The Development Of Alzheimer's Disease Biomarker Assays 1/10/2014 8:42:13 AM
Probiodrug AG Divests Its CDK9 Inhibitor Program To AstraZeneca PLC (AZN) For Undisclosed Price 1/3/2014 7:01:22 AM
Probiodrug AG Funds Brigham and Women's Hospital’s Research Into Antibody Targeting Pyroglutamated Abeta For Treatment Of Alzheimer’s Disease 12/23/2013 9:26:53 AM
Probiodrug AG Provides Update on Clinical Development of PQ912, Its Most Advanced QC-Inhibitor for Alzheimer's Disease 7/16/2013 10:05:35 AM